BARRY GRAHAM: Open Payments
NPI 1891821435 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 62 payments from 14 companies in 2025. Trend: 2023 $657 · 2024 $1,132 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $297 |
| Paratek Pharmaceuticals, Inc. | 10 | $174 |
| PFIZER INC. | 10 | $154 |
| GlaxoSmithKline, LLC. | 7 | $141 |
| Lilly USA, LLC | 6 | $98 |
| Novo Nordisk Inc | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Abbott Laboratories | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: BREZTRI, NUZYRA, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, REXULTI, PAXLOVID, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
